This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Integrated Biotherapeutics, Inc., University System of Maryland. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 9 
1 out of 2,029 
Years Active: 2021
Title: Inventor Spotlight: Xuelian Zhao and His Contribution to Ebolavirus Research
Introduction: Xuelian Zhao, based in Gaithersburg, MD, has made significant strides in the field of infectious diseases through his innovative work on ebolavirus. With one patent to his name, Zhao's research focuses on developing novel methods to combat ebolavirus infections, showcasing the impact and importance of his contributions in medical science.
Latest Patents: Xuelian Zhao holds a patent for a "Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop." This patent addresses a critical area in virology, providing a method for preventing, treating, or managing an ebolavirus infection. The innovative method includes administering an effective amount of at least one pan-ebolavirus internal fusion loop antibody or antigen-binding fragment that specifically targets the epitope on multiple ebolavirus species or strains. This breakthrough holds potential for enhancing therapeutic strategies against deadly ebolaviruses.
Career Highlights: Over the course of his career, Xuelian Zhao has worked for Integrated Biotherapeutics, Inc. and the University of Maryland, College Park. His experience in these prominent institutions has allowed him to collaborate on extensive research projects and develop his skills in biotherapeutics, making impactful contributions in his field.
Collaborations: Throughout his career, Zhao has collaborated with esteemed colleagues, including Mohammad Javad Aman and Katie A Howell. These partnerships highlight the collaborative spirit that is essential in scientific research, especially in developing vaccines and treatments for significantly dangerous pathogens such as ebolavirus.
Conclusion: Xuelian Zhao's dedication to advancing ebolavirus research is evident through his innovative patent and fruitful collaborations. His work continues to be an important asset in the fight against infectious diseases, and his contributions are likely to lead to further advancements in medical treatment and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile